Institution
University of Victoria
Education•Victoria, British Columbia, Canada•
About: University of Victoria is a education organization based out in Victoria, British Columbia, Canada. It is known for research contribution in the topics: Population & Galaxy. The organization has 14994 authors who have published 41051 publications receiving 1447972 citations. The organization is also known as: Victoria College.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A systematic analysis of eighty-eight journal articles published over the last two decades reveals that IEEE research is a vibrant and rapidly growing stream of the broader international entrepreneurship (IE) domain, and that it is methodologically and topically diverse as mentioned in this paper.
480 citations
••
TL;DR: In this article, the CCCma coupled general circulation model control simulation exhibits a robust and realistic AO and AAO, with forcing due to greenhouse gases and aerosols, exhibit positive trends in both the AO/AAO and the AAO.
Abstract: The Arctic Oscillation (AO) and the Antarctic Oscillation (AAO) are the leading modes of high-latitude variability in each hemisphere as characterized by the first EOF of mean sea-level pressure. Observations suggest a recent positive trend in the AO and it is speculated that this may be related to global warming. The CCCma coupled general circulation model control simulation exhibits a robust and realistic AO and AAO. Climate change simulations for the period 1900–2100, with forcing due to greenhouse gases and aerosols, exhibit positive trends in both the AO and the AAO. The model simulates essentially unchanged AO/AAO variations superimposed on a forced climate change pattern. The results do not suggest that a simulated trend in the AO/AAO necessarily depends on stratospheric involvement nor that forced climate change will be expressed as a change in the occurence of one phase of the AO/AAO over another. This pattern of climate change projects exclusively on the AAO pattern in the southern hemisphere but not in the northern hemisphere where other EOFs are involved. The extent to which this forced climate change pattern and the unforced modes of variation are determined by the same mechanisms and feedbacks remains an open question.
478 citations
••
University of Melbourne1, Université libre de Bruxelles2, Katholieke Universiteit Leuven3, University of Victoria4, St. Vincent's Health System5, La Trobe University6, Royal Melbourne Hospital7, Netherlands Cancer Institute8, University of California, San Diego9, Vanderbilt University10, Peter MacCallum Cancer Centre11, University of Antwerp12, University of Paris13, French Institute of Health and Medical Research14, Medical University of Vienna15, Cornell University16, University of Texas MD Anderson Cancer Center17, Mayo Clinic18, Royal Brisbane and Women's Hospital19, University of Queensland20, Harvard University21, Novartis22, Indiana University – Purdue University Indianapolis23, Fred Hutchinson Cancer Research Center24, University of Milan25, University of Auvergne26, Kansai Medical University27, Yeshiva University28, Yonsei University29, Rhode Island Hospital30, Brown University31, Curie Institute32, Charité33, Yale University34, University of British Columbia35, Garvan Institute of Medical Research36, Université Paris-Saclay37, Autonomous University of Madrid38, University of Ottawa39, National Institutes of Health40, New York University41, University of Adelaide42, Stanford University43, Anschutz Medical Campus44, University of Padua45, European Organisation for Research and Treatment of Cancer46, Medical University of Graz47, Hoffmann-La Roche48, Genentech49, MedImmune50, Merck & Co.51, Memorial Sloan Kettering Cancer Center52
TL;DR: Standardization of TIL assessment will help clinicians, researchers and pathologists to conclusively evaluate the utility of this simple biomarker in the current era of immunotherapy.
Abstract: Assessment of the immune response to tumors is growing in importance as the prognostic implications of this response are increasingly recognized, and as immunotherapies are evaluated and implemented in different tumor types. However, many different approaches can be used to assess and describe the immune response, which limits efforts at implementation as a routine clinical biomarker. In part 1 of this review, we have proposed a standardized methodology to assess tumor-infiltrating lymphocytes (TILs) in solid tumors, based on the International Immuno-Oncology Biomarkers Working Group guidelines for invasive breast carcinoma. In part 2 of this review, we discuss the available evidence for the prognostic and predictive value of TILs in common solid tumors, including carcinomas of the lung, gastrointestinal tract, genitourinary system, gynecologic system, and head and neck, as well as primary brain tumors, mesothelioma and melanoma. The particularities and different emphases in TIL assessment in different tumor types are discussed. The standardized methodology we propose can be adapted to different tumor types and may be used as a standard against which other approaches can be compared. Standardization of TIL assessment will help clinicians, researchers and pathologists to conclusively evaluate the utility of this simple biomarker in the current era of immunotherapy.
477 citations
••
Broad Institute1, Eli Lilly and Company2, University of Victoria3, Institute for Systems Biology4, University of Washington5, ETH Zurich6, University of California, San Francisco7, University of South Florida8, Vanderbilt University9, Pacific Northwest National Laboratory10, Food and Drug Administration11, Pfizer12, Fred Hutchinson Cancer Research Center13, Purdue University14, National Institutes of Health15, Centers for Disease Control and Prevention16, Johns Hopkins University17, Korea University18, Harvard University19, Emory University20, Washington University in St. Louis21, Leidos22, University of Texas Health Science Center at San Antonio23
TL;DR: A workshop was held at the National Institutes of Health with representatives from the multiple communities developing and employing targeted MS assays and defined three tiers of assays distinguished by their performance and extent of analytical characterization.
476 citations
••
TL;DR: In this article, the authors show that the legitimacy of the top management team (TMT) may serve as a valid signal of value to potential investors, and support a previously unexplored view of the TMT as an important signal for value in IPOs.
Abstract: The condition of information asymmetry between current owners and potential IPO investors creates a context wherein the legitimacy of the top management team (TMT) may serve as a valid signal of value to potential investors. The results confirm our hypotheses that TMT legitimacy is negatively correlated with post-IPO stock value run-up. Our results support a previously unexplored view of the TMT as an important signal of value in IPOs, and suggest that dual benefits accrue to the TMT selection process in IPO firms. Copyright © 2005 John Wiley & Sons, Ltd.
474 citations
Authors
Showing all 15188 results
Name | H-index | Papers | Citations |
---|---|---|---|
Jie Zhang | 178 | 4857 | 221720 |
D. M. Strom | 176 | 3167 | 194314 |
Sw. Banerjee | 146 | 1906 | 124364 |
Robert J. Glynn | 146 | 748 | 88387 |
Manel Esteller | 146 | 713 | 96429 |
R. Kowalewski | 143 | 1815 | 135517 |
Paul Jackson | 141 | 1372 | 93464 |
Mingshui Chen | 141 | 1543 | 125369 |
Ali Khademhosseini | 140 | 887 | 76430 |
Roger Jones | 138 | 998 | 114061 |
Tord Ekelof | 137 | 1212 | 91105 |
L. Köpke | 136 | 950 | 81787 |
M. Morii | 134 | 1664 | 102074 |
Arnaud Ferrari | 134 | 1392 | 87052 |
Richard Brenner | 133 | 1108 | 87426 |